93483-92-2

Basic information

• Product Name: Ethanone, 1-(5-amino-2-hydroxy-4-methoxyphenyl)-
• CAS NO: 93483-92-2
• Molecular Formula: C9H11NO3
• Molecular Weight: 181.191
• Mol File: 93483-92-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Ethanone, 1-(5-amino-2-hydroxy-4-methoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-(5-amino-2-hydroxy-4-methoxyphenyl)-(93483-92-2)
• EPA Substance Registry System: Ethanone, 1-(5-amino-2-hydroxy-4-methoxyphenyl)-(93483-92-2)

Safety Data

• Hazardous Substances Data: 93483-92-2(Hazardous Substances Data)

Upstream product

• 89-84-9 2',4'-dihydroxy-4-acetophenone 
• 552-41-0 1-(2-hydroxy-4-methoxyphenyl)ethanone 
• 102877-53-2 1-(2-hydroxy-4-methoxy-5-nitrophenyl)ethanone 
• 829-20-9 2',4'-dimethoxyacetophenone 

Downstream Products

• 113184-47-7 5'-acetylamino-2'-hydroxy-4'-methoxy-3,4-methylenedioxy-trans-chalcone 
• 101730-64-7 6-amino-2-(3,4-dimethoxy-phenyl)-7-methoxy-chroman-4-one 
• 109395-47-3 6-amino-7-methoxy-2-(2-methoxy-phenyl)-chroman-4-one 
• 102012-99-7 acetic acid-[5-(3,4-dimethoxy-trans-cinnamoyl)-4-hydroxy-2-methoxy-anilide] 
• 111935-97-8 acetic acid-[4-hydroxy-2-methoxy-5-(2-methoxy-trans-cinnamoyl)-anilide] 
• 103796-24-3 N-(5-acetyl-4-hydroxy-2-methoxyphenyl)acetamide 
• 116265-99-7 1-(5-chloro-2-hydroxy-4-methoxyphenyl)ethanone 
• 22089-12-9 2,5-dihydroxy-4-methoxyacetophenone 
• 39503-61-2 1-(5-bromo-2-hydroxy-4-methoxyphenyl)ethanone 

Relevant articles and documents

-

-

COMPOUNDS FOR THE TREATMENT OF AMYLOID-ASSOCIATED DISEASES

This invention provides novel compounds of formulae (I) or (II) or a stereoisomer, enantiomer, racemic, or tautomer thereof, (I) (II) wherein the substituents are as defined in the specification. The present invention also relates to the novel compounds for use as a medicine, more in particular for the prevention or treatment of amyloid-related diseases, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, disorders characterized by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such amyloid-related diseases. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.